Cohere Health, a clinical intelligence company, has secured $90 million in Series C funding to accelerate the growth of its clinical intelligence platform for health plans and risk-bearing providers.
Here are five things to know:
The round was led by Temasek, with participation from Deerfield Management, Define Ventures, Flare Capital Partners, Longitude Capital and Polaris Partners. This brings the company’s total funding to $200 million, according to a May 14 press release.
The new capital will support scaling the Cohere Unify platform, expanding to new clinical use cases, and investing in AI-powered product development.
Cohere Unify modernizes utilization management by integrating real-time provider performance data, automating prior authorizations, and supporting clinical decision-making with precision insights.
The company processes over 12 million prior authorization requests annually for more than 600,000 providers nationwide.
Cohere’s platform enables up to 90% of requests to be auto-approved, helping reduce provider burden and expedite patient care.
